Skip to content
GLP-1 Scorecard
Menu
Graded #256

Medro

Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group and…

Visit MedroWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$199/mo (compounded)
Tirzepatide
$299/mo (compounded)
Coverage
All 50 states
Brand-name
Yes

Weigh Medro against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value50/100
Dose & formulation77/100
Clinical oversight71/100
Labs & monitoring52/100
Fulfillment92/100
Contract terms33/100

Strengths

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

Where it loses points

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

Bottom line — Grade C

Best for: Shoppers who want compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states.

Ranked #256 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Medro — the realistic shortlist.

The 20 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Medro's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Medro's site. Not medical advice; see our disclosure.

← Back to the scorecard